临床试验知情同意过程中受试者理解度的测量与评估:一项系统综述
该系统综述检索至2023年3月的文献,纳入148项研究,评估临床试验知情同意过程中测量受试者理解度的工具或方法。仅三种工具(DICCQ、PIC、P-QIC)显示高质量心理测量学特性,而最常用的QuIC问卷方法学质量较低,患者与公众参与工具开发报告不足。
要点
- 仅DICCQ、PIC和P-QIC三种工具显示高质量心理测量学特性。
- 最常用的QuIC问卷报告的心理测量学方法学质量相对较低。
- 患者与公众参与测量工具开发的情况报告不频繁且范围有限。
核心结论
- 综述揭示了心理测量学严谨性与常规实践之间的脱节,需加强评估方法的验证与标准化,并更一致地整合患者与公众视角。
研究设计与样本
- 系统综述,检索电子数据库自建库至2023年3月,纳入148项研究,含103项定量、24项混合方法和20项定性研究。
主要发现
- 共筛选6526条记录,261项研究全文筛选,最终纳入148项研究。
- 仅三种工具(DICCQ、PIC、P-QIC)显示高质量心理测量学特性。
- 最常用的QuIC问卷报告的心理测量学方法学质量相对较低。
- 患者与公众参与工具开发报告不频繁且范围有限。
临床怎么用
- 临床研究中测量知情同意理解度时,可优先考虑心理测量学特性高质量的DICCQ、PIC或P-QIC工具。
- 应加强评估工具的验证与标准化,并在工具开发与验证中更一致地纳入患者与公众视角。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Informed consent (IC) is essential for maintaining participant autonomy in clinical trials by ensuring participants are fully informed. However, inconsistent oversight of spoken information provision and participant comprehension of both written and spoken information can lead to significant gaps in participant understanding and recall of critical trial details. This systematic review (SR) evaluates existing tools or approaches that measure participant understanding during the IC process. It will further focus on the quality of data regarding the validity and reliability of these methods. METHODS: Relevant primary studies were identified through searching electronic databases from inception to March 2023. Studies included adults who had undergone the IC process for research. Following screening, data extraction was performed using a customised Microsoft Excel template, focusing on characteristics including validity, reliability, and patient and public involvement in the development of tools/measures used to assess participant understanding. Narrative synthesis was used to descriptively organise and summarise findings across studies, including study characteristics, assessment timing, and types of tools or approaches used, while psychometric properties were evaluated using the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) framework. RESULTS: Of the 6526 records screened, 261 studies were retrieved for full-text screening and a total of 148 studies were included in the review. Among these studies, 103 were quantitative, 24 were mixed methods, and 20 were qualitative studies. This SR identified variability across tools/measures and approaches used in clinical trials to measure participant understanding of IC. Only three tools demonstrated high-quality psychometric properties, i.e. the Digitised Informed Consent Comprehension Questionnaire (DICCQ), the Participatory and Informed Consent (PIC) tool, and the Process and Quality of Informed Consent (P-QIC). Notably, the most frequently used tool across studies, the Quality of Informed Consent (QuIC) questionnaire, demonstrated relatively low methodological quality in its reported psychometric properties. In addition, patient and public involvement in the development of these tools was infrequently reported and often limited in scope. CONCLUSIONS: This review highlights a disconnect between psychometric rigour and common practice. It also emphasises the need to strengthen the validation and standardisation of assessment approaches, alongside more consistent and meaningful integration of patient and public perspectives in their development and validation. REGISTRATION: PROSPERO ID: CRD42023407715. Version 1.1, published 14 Aug 2025. Version 1.0, published 22 Mar 2023.
引用
- Faisal S, Wade J, Dos Santos J, et al. Measuring and evaluating participant understanding of consent processes in clinical trials: a systematic review. Trials. 2026. PMID: 41781998. doi:10.1186/s13063-026-09582-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。